Artiva Biotherapeutics (ARTV) Amortizatization of Intangibles (2023 - 2026)
Artiva Biotherapeutics' (ARTV) quarterly Amortizatization of Intangibles came in at $199000.0 in Q1 2026, down 72.48% year-on-year from $723000.0 in Q1 2025, and down 31.62% on a QoQ basis from $291000.0 in Q4 2025.
Artiva Biotherapeutics (ARTV) Amortizatization of Intangibles (2023 - 2026) Analysis & Trends
Artiva Biotherapeutics (ARTV) has 4 years of Amortizatization of Intangibles data on file, last reported at $199000.0 in Q1 2026.
- On a quarterly basis, Amortizatization of Intangibles fell 72.48% year-over-year to $199000.0 in Q1 2026; TTM through Mar 2026 was $1.4 million, a 49.72% decrease from a year earlier, with the FY2025 full-year figure at $1.9 million, down 19.73% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $199000.0, down from $291000.0 in the prior quarter.
- Over the last five years, Amortizatization of Intangibles for ARTV reached as high as $1.0 million in Q4 2024 and fell as low as $199000.0 in Q1 2026.
- Historically, Amortizatization of Intangibles has averaged $470400.0 across 4 years, with a median of $362500.0 in 2024.
- Across the five-year window, Amortizatization of Intangibles soared 268.2% in 2024 and sank 72.48% in 2026, its largest moves.
- Year by year, Amortizatization of Intangibles stood at $283000.0 in 2023, then surged by 268.2% to $1.0 million in 2024, then slumped by 72.07% to $291000.0 in 2025, then tumbled by 31.62% to $199000.0 in 2026.
- Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $199000.0 in Q1 2026, $291000.0 in Q4 2025, and $357000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Artiva Biotherapeutics | 256.04 Mn | 256.04 Mn | - | 199,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 199,000.00 |
| Mar 31, 2026 | 199,000.00 |
| Dec 31, 2025 | 291,000.00 |
| Dec 31, 2025 | 291,000.00 |
| Sep 30, 2025 | 357,000.00 |
| Sep 30, 2025 | 357,000.00 |
| Jun 30, 2025 | 509,000.00 |
| Jun 30, 2025 | 509,000.00 |
| Mar 31, 2025 | 723,000.00 |
| Mar 31, 2025 | 723,000.00 |
| Dec 31, 2024 | 1.04 Mn |
| Dec 31, 2024 | 1.04 Mn |
| Sep 30, 2024 | 659,000.00 |
| Sep 30, 2024 | 659,000.00 |
| Jun 30, 2024 | 273,000.00 |
| Jun 30, 2024 | 273,000.00 |
| Mar 31, 2024 | 368,000.00 |
| Mar 31, 2024 | 368,000.00 |
| Dec 31, 2023 | 283,000.00 |
| Dec 31, 2023 | 283,000.00 |